(Q43891590)

27 November 2017

title

Regulation of herpes simplex virus 1 replication using tumor-associated promoters (English)

1 reference

27 November 2017

5

Timothy M Pawlik

1 reference

27 November 2017

John T Mullen

1

1 reference

27 November 2017

Hideki Kasuya

2

1 reference

27 November 2017

Sam S Yoon

3

1 reference

27 November 2017

Nancy M Carroll

4

1 reference

27 November 2017

Soundararajalu Chandrasekhar

6

1 reference

27 November 2017

Hideo Nakamura

7

1 reference

27 November 2017

James M Donahue

8

1 reference

27 November 2017

Kenneth K Tanabe

9

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

236

1 reference

27 November 2017

issue

4

1 reference

27 November 2017

page(s)

502-12; discussion 512-3

1 reference

Reovirus therapy of tumors with activated Ras pathway

27 November 2017

cites work

1 reference

12 December 2020

B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells

1 reference

12 December 2020

An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma

1 reference

12 December 2020

Newcastle disease virus (NDV): brief history of its oncolytic strains

1 reference

12 December 2020

Conditionally replicating herpes vectors for cancer therapy

1 reference

12 December 2020

Human gene marker/therapy clinical protocols

1 reference

12 December 2020

Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus

1 reference

12 December 2020

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

1 reference

12 December 2020

Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vector.

1 reference

12 December 2020

Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil.

1 reference

12 December 2020

Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.

1 reference

12 December 2020

Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma

1 reference

12 December 2020

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

1 reference

12 December 2020

Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4.

1 reference

12 December 2020

Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas

1 reference

12 December 2020

Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant

1 reference

12 December 2020

Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine.

1 reference

12 December 2020

Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant

1 reference

12 December 2020

Transcriptional regulation of DF3 gene expression in human MCF-7 breast carcinoma cells

1 reference

12 December 2020

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus)

1 reference

12 December 2020

The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells

1 reference

12 December 2020

Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene

1 reference

12 December 2020

Transcriptional Regulatory Sequences of Carcinoembryonic Antigen: Identification and Use with Cytosine Deaminase for Tumor-Specific Gene Therapy

1 reference

12 December 2020

Delivery of molecular medicine to solid tumors

1 reference

12 December 2020

Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus

1 reference

12 December 2020

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

12 December 2020

Seroprevalence of and risk factors for antibodies to herpes simplex viruses, hepatitis B, and hepatitis C among southwestern Hispanic and non-Hispanic white women

1 reference

12 December 2020

The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-

1 reference

12 December 2020

Transcriptional targeting of herpes simplex virus for cell-specific replication

1 reference

12 December 2020

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

1 reference

12 December 2020

Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector

1 reference

12 December 2020

MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis

1 reference

12 December 2020

Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy

1 reference

12 December 2020

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

1 reference

12 December 2020

Gene therapy death prompts review of adenovirus vector

1 reference

12 December 2020

10.1097/00000658-200210000-00013

Identifiers

DOI

1 reference

27 November 2017

0 references

1 reference